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Abstract
Background: Measurements on gene level are widely used to gain new insights in
complex diseases e.g. cancer. A promising approach to understand basic biological
mechanisms is to combine gene expression profiles and classical clinical parameters.
However, the computation of a correlation coefficient between high-dimensional
data and such parameters is not covered by traditional statistical methods.
Methods: We propose a novel index, the Normalized Tree Index (NTI), to compute a
correlation coefficient between the clustering result of high-dimensional microarray
data and nominal clinical parameters. The NTI detects correlations between
hierarchically clustered microarray data and nominal clinical parameters (labels) and
gives a measurement of significance in terms of an empiric p-value of the identified
correlations. Therefore, the microarray data is clustered by hierarchical agglomerative
clustering using standard settings. In a second step, the computed cluster tree is
evaluated. For each label, a NTI is computed measuring the correlation between that
label and the clustered microarray data.
Results: The NTI successfully identifies correlated clinical parameters at different
levels of significance when applied on two real-world microarray breast cancer data
sets. Some of the identified highly correlated labels confirm the actual state of
knowledge whereas others help to identify new risk factors and provide a good basis
to formulate new hypothesis.
Conclusions: The NTI is a valuable tool in the domain of biomedical data analysis. It
allows the identification of correlations between high-dimensional data and nominal
labels, while at the same time a p-value measures the level of significance of the
detected correlations.
Background
Hierarchical agglomerative clustering is the basis for most visual data mining tasks in
microarray applications [1-3]. Compared to non-hierarchical cluster algorithms, it has
the advantage that the number of clusters does not have to be specified in advance.
This property is of utmost importance since the number of clusters is usually unknown
making a precise a priori prediction of the number of clusters impossible. A second
reason for the frequent application of hierarchical agglomerative clustering is its visua-
lization ability [4]. The intrinsic hierarchical cluster structure of the data becomes
visually accessible at once in the computed cluster tree. The visualization ability of
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computed cluster trees is especially valuable to analyze complex biomedical data, con-
sisting of primary data and secondary data. The primary data is obtained in the main
experiment whereas the secondary data includes all supplementary data about the ana-
lyzed subjects. In the context of gene expression analysis, the primary data is the gene
expression data from the microarray experiments. The corresponding secondary data
consists of clinical data, disease outcome, information about the applied treatments
and therapies, as well as gene annotations. It is common practice to visualize the com-
puted cluster tree in combination with the clustered microarray data (the primary
data) and the secondary data available for the clustered samples (Figure 1).
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Figure 1 Visualization of clustered microarray data and clinical data. The gene expression data
(primary data) is displayed by colored squares, each one representing a specific gene and sample. A green
square represents an up-regulation, a black square an unchanged expression and a red square a down-
regulation compared to reference. The microarray data is clustered both with respect to subjects and
genes (a). The hierarchical clustering result is displayed as a tree on the top and on the left side of the
data (b and c). The rows and columns are permuted according to the leaves of the cluster trees. Clinical
data (secondary data) available for the subjects is displayed between the top cluster tree and the
microarray data (d).
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Microarray technology is currently entering the field of medicine [5,6]. In order to
identify molecular factors for macroscopic observations and diseases, recent medical
studies often incorporate both gene expression data as well as a high number of clini-
cal parameters [7]. Most mechanisms for development and proliferation of complex
diseases (e.g., cancer) are still unknown. It is supposed that many new insights into
the mechanisms of diseases can be obtained when the microarray data (primary data)
is analyzed in combination with the clinical data (secondary data) consisting of mas-
ter data, vital data, laboratory data and outcomes (with respect to diseases of interest)
that is available for each subject. In few cases, a single gene directly determines the
macroscopic phenotype (e.g., eye color). However, most macroscopic phenotypes ori-
ginate from a set of genes, denoted as gene profiles or metagenes [8]. Clinical data
can be considered as a set of observations on the phenotypic level. There are observa-
tions on the molecular level (e.g., protein expression), macroscopic observations (e.g.,
skin color, tumor size, outcome) as well as behavioral observations (e.g., nutrition,
alcohol consumption, sport). One issue of interest to the researcher is the identifica-
tion of clinical parameters (labels) that are correlated with the microarray data.
A high correlation between a label and the microarray data indicates that there might
be a common underlying mechanism or pathway. This provides a good basis to for-
mulate new hypothesis and to obtain new insights into the complex mechanisms of
diseases.
The visual inspection of cluster trees allows the estimation of the correlation
between the label and the clustered microarray data. However, this approach becomes
infeasible for studies with large numbers of samples and a high number of different
labels. Furthermore, the number of labels available for each subject is continuously
increasing, since hospital information systems store large amounts of laboratory and
vital data as well as radiological and microbiological findings in huge databases [9].
Therefore, an automated and objective computation of the correlation between labels
and microarray data is needed to identify correlated clinical parameters.
The canonical way to compute the correlation between a label and the microarray
data is to compute the correlation between the label (first variable) and every single
gene (second variable), and to combine the results in a final correlation coefficient.
Depending on the type of variables, statistics provides various methods to compute the
correlation between two variables. For interval data, Pearson’s correlation coefficient r
[10] computes the correlation between two variables whereas each variable is normal-
ized to zero mean and unit variance beforehand. For ordinal data, the correlation
between two variables can be computed using Spearman’s rank correlation coefficient
r [11]. This robust measure can even be applied on small sample sizes, but it requires
that the original data of any two successive ranks has to be approximately equidistant.
In cases where this can not be assumed, Kendall’s τ [12] should be used instead. For
nominal data, the chi-square test, Pearson’s contingency coefficient, or the corrected
contingency coefficient measure the correlation between any two variables [11].
A major drawback of the different correlation and contingency coefficients is that
they can only be used to compute the correlation between a label and a single gene.
Information contained in metagenes or gene profiles cannot be assessed this way.
Thus, a direct computation of the correlation between a label and single genes in
order to identify correlated labels does not capture the major trend of information
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hidden in the data. Microarray data rather has to be considered in its entirety, and an
analysis always has to be done in an holistic way.
In this paper, we propose a novel index, the Normalized Tree Index (NTI), which is
an extension of the Tree Index (TI) proposed in [13]. The NTI computes a correlation
coefficient between the clustering result (tree structure) of high-dimensional primary
data (here: microarray data) and associated nominal labels of secondary data (here:
clinical parameters). Due to a normalization procedure it is bounded by [0, 1]. A high
NTI indicates a high correlation between the label and the clustered data and vice
versa.
Furthermore, an empirical p-value is derived which measures the level of significance
of the detected correlations between labels and clustered microarray data. In a first
step, the microarray data is clustered by hierarchical agglomerative clustering using
standard settings (Figure 2). Thereby, the complete microarray data is taken into
account. In a second step, the computed cluster tree is evaluated using the NTI. For
each label, one NTI is computed measuring the correlation between that label and the
clustered microarray data. By this approach the microarray data is considered in its
entirety and labels that are correlated with the microarray data can be identified. The
NTI extends the TI in many respects: First, the normalization procedure increases the
interpretability of the correlation result considerably. The TI has been biased with
respect to the number of classes of the label, the number of elements of each class,
and the number of missing values. This unwanted feature prevents an objective corre-
lation analysis with different labels whose number of classes vary. Second, the compu-
tation of the p-value: The p-value is a valuable parameter for the biomedical researcher
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Figure 2 Computing the correlation between clinical parameters and microarray data. The
Normalized Tree Index (NTI) is used to compute a correlation coefficient between the clustering result
(tree structure) of high-dimensional primary data (microarray data) and associated nominal labels of
secondary data (clinical parameters). In a first step, the microarray data is clustered by hierarchical
agglomerative clustering using standard settings. In a second step, the computed cluster tree is evaluated
using the NTI. For each label, a NTI is computed that measures the correlation between that label and the
clustered microarray data. This permits the identification of labels that are highly correlated with the
microarray data, while analyzing the microarray data in its entirety.
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since it measures the level of significance of any detected correlation. Both the normal-
ization and the p-value enables us to automatically detect correlations between clus-
tered genomic data (primary data) and many different clinical parameters (secondary
data). Thus, the scope of this paper is far beyond that of [13], which was to improve
the clustering process for one fixed clinical parameter by detecting the most appropri-
ate parametric setting to obtain the best clustering result. In this paper, we aim to dis-
cover new relationships between genomic data and macroscopic observations. We
rather focus on knowledge discovery in data bases (KDD) than on a pure data mining
task.
The NTI is successfully applied on two breast cancer data sets to compute correla-
tions between microarray data and clinical data. Some of the identified highly corre-
lated labels confirm the actual state of knowledge in breast cancer research (i.e.
progesterone IHC, estrogen IHC). Others are helpful to identify new risk factors and
provide a good basis to formulate new hypothesis and to obtain new insights into the
complex mechanisms and pathways of diseases.
Methods
Cluster indices are cluster validation techniques that provide an objective measure of a
clustering result. They can be grouped into internal and external ones [14-16]. Internal
cluster indices evaluate the quality of a clustering result by using only intrinsic informa-
tion of the data. In contrast to that, external cluster indices permit an entirely objective
evaluation by making use of the knowledge of an external class label, denoted as label in
the following. The Tree Index (TI) is an external cluster index for cluster trees [13]. It is
used to identify the algorithm and parameterization yielding the clustering that is best
suited for visualization. However, the TI has the drawback that it is biased with respect
to the number of classes of the label, the number of elements of each class, and the
number of missing values. This unwanted feature prevents an objective correlation ana-
lysis with different labels whose number of classes vary. To overcome this problem, an
extension to the TI, the Normalized Tree Index (NTI), is developed. The Normalized
Tree Index (NTI) computes a normalized correlation coefficient between hierarchically
clustered primary data (microarray data) and nominal labels of secondary data (clinical
parameters). Furthermore, a p-value is derived that measures the level of significance of
the detected correlation between labels and clustered data. The NTI and the corre-
sponding p-value are computed for each label of the secondary data.
The Tree Index (TI)
Let the primary data be a dataset  of d samples of length g:  = {x1, ..., xi, ..., xd},
length (xi) = g. In the context of microarray data analysis,  can be a preprocessed
microarray data set with d tissue samples and g genes. A label c (dim (c) = d) is
selected from the secondary data for correlation analysis (e.g., grading), with
ci ∈{ ,...., } 1  , i = 1, ..., d and  the number of classes (e.g., the number of gradings).
Let  be clustered by hierarchical agglomerative clustering. After the clustering, the
TI is computed for each label on the resulting cluster tree.
The Tree Index (TI) considers the cluster tree as a result of a statistical splitting pro-
cess. It is based on the evaluation of probabilities of every single split in the tree start-
ing from the root (i.e. the entire dataset is one cluster). In a first step, a splitting score
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is computed for every single split in the tree based on the probability of the split. In a
second step, all splitting scores are combined to compute the final TI.
Step 1 Let the cluster of the r-th split (the splits are numbered arbitrarily) contain N
elements. Let the cluster be split into l (usually l = 2) smaller subclusters. The ele-
ments of the main cluster belong to  different categories whereas nl, l Î {1, ..., }
specifies the number of elements belonging to class  . The i-th subcluster contains
mi elements with mil elements belonging to class  . The primary objective is to
compute the probability of such a particular split by taking the observed class distribu-
tions in the clusters into account. It is assumed that mi, i Î {1, ..., l} elements are
drawn from the N elements by sampling without replacement. Thereby each element
is drawn with the same probability. The probability of the observed class distribution
in the splitted clusters is given by a generalized form of the polyhypergeometric distri-
bution or multivariate hypergeometric distribution [17]. Let M = {mil}, n = {nl}, and
m = {mi} with 1 ≤ i ≤ l and 1 ≤ l ≤ .
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p(M; N, n, m) decreases with the size of the cluster that is split and with the homo-
geneity of the subclusters. The splitting score Sr of the r-th split is defined by its nega-
tive logarithmic probability.
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Step 2 The TI combines the complete set of splitting scores to a parameter-free
index by computing the standard deviation of splitting scores:
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and R being the number of splits in the cluster tree. The higher the index for a given
label, the higher the correlation between that label and the clustered primary data (Fig-
ure 3). As stated earlier in this section, the TI is biased with respect to the number of
classes of the label. If the number of classes of the label increases, the TI also
increases. This is due to the fact, that p(M; N, n, m) decreases if the number of classes
and thus the number of possible class distributions increases. This leads to higher
splitting scores and thus a higher TI. For a more detailed description of the TI, please
refer to [13].
The Normalized Tree Index (NTI)
The Normalized Tree Index (NTI) computes a normalized correlation coefficient
between nominal parameters and hierarchically clustered data. In order to avoid biases
with respect to the number of classes and the distribution of cluster sizes [14,15], the
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TI is normalized as suggested in [15]. It should be noted that this normalization proce-
dure does not lead to an unbiased correlation coefficient in a strong statistical sense.
The distribution of the TI for different number of classes and cluster sizes is not taken
into account. After the normalization, the expectation E[NTI] is still unknown. We
propose to empirically calculate TImin and (TImax) for each considered label by using a
Monte Carlo simulation (Figure 4):
To compute TImin, the labels are permuted r ≥ 10000 times (Figure 4b), whereas the
cluster tree remains unchanged. For each randomly permuted label and each random
cluster tree, a TI is computed. The lowest TI is an empirical estimation for TImin.
To compute TImax, r ≥ 10000 ordered labels and ordered cluster trees are generated
(Figure 4c). An ordered cluster tree consists of  pure subtrees, each one containing
all items belonging to one class. The internal structure of each pure subtree is of no
importance and is chosen arbitrary. Based on the  pure subtrees, the ordered tree is
constructed by merging two randomly selected subtrees in  - 1 agglomerative steps.
The ordered label is constructed respectively. For each ordered label and each ordered
cluster tree, a TI is computed. The highest TI is an empirical estimation for TImax.
With the estimations for TImin and TImax, the NTI is defined by
NTI
TI TI
TI TImax
=
−
−
min
min
(4)
The NTI is bounded by [0, 1]. However, the empirical computation of TImin and
TImax implies that there might be a TI < TImin or a TI > TImax. In such a case, the
NTI should be set to 0 or 1, respectively. To reduce the probability for such events, r
should be set sufficiently large.
A high NTI indicates a high correlation between the label and the clustered data and
vice versa.
Computation of p-value
Natural fluctuation in the data can lead to constellations in which the clustered data
seems to be correlated with external labels, but in fact the correlation has occurred by
microarray data (primary data)
a) low correlation b) moderate correlation c) high correlation
TI = 0.77 TI = 2.07 TI = 4.59label
hierarchical agglomerative clustering
Figure 3 Correlation between different microarray data sets and a label. The correlation between
three different microarray data sets and a label is analyzed using the TI. In (a), there is only a low
correlation between the microarray data and the label, resulting in a TI of 0.77. A TI of 2.07 indicates a
moderate correlation in (b), whereas a high correlation (TI = 4.59) is shown in (c).
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chance. The computation of a p-value allows the detection of such false identifications
of correlations. This approach has already been successfully applied for the biological
homogeneity index (BHI) and the biological stability index (BSI) [18].
Let H0 be the null hypothesis that there is no correlation between the microarray
data and a clinical parameter. A p-value lower than a significance level of 5%, 1%, or
0.1% means a rejection of H0. The p-value can either be derived analytically or empiri-
cally. Here, a Monte Carlo simulation is used to compute an empirical p-value for the
TI and NTI. For simplicity, the computation of the p-value is derived for the TI.
Let t be the TI of the tree obtained by a hierarchical cluster algorithm (e.g., hierarch-
ical agglomerative clustering). The empirical p-value is defined by the fraction of TIs
obtained from trees with randomly permuted labels (Figure 4b) that is equal or higher
than t (Figure 5):
p du
u t
=
≥
∞∫ (5)
For practical use, p can be approximated by
p
r
i
t t
r
i
≈
=
>
∑1 1
1
(6)
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Figure 4 Lower and upper bound for the TI. The cluster tree that is obtained when applying
hierarchical agglomerative clustering to the primary data is shown in (a). The branches and leaves of the
cluster tree are colored according to the given label. Missing values are colored in black. In (b) the labels
are permuted r times. The cluster tree with the lowest TI (underlined) is an empirical estimation for TImin.
The TIs are also used to compute the respective p-value. In (c) r ordered cluster trees and ordered labels
are generated. The cluster tree with the highest TI (underlined) is an empirical estimation for TImax.
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with ti being the TI of the clustered tree with the i-th randomly permuted label. A
p ≥ 0.05 means that H0 (no correlation) cannot be rejected. A p < 0.05 (0.01, 0.001)
means that the rejection of H0 is statistically significant at the 5% (1%, 0.1%) level. The
number r of randomly permuted labels has to be sufficiently large to obtain a statistical
significant rejection of H0 at the 5% (1%, 0.1%) level. r > 1000 random trees are
required to theoretically achieve a statistical significant rejection of H0 at the 0.1%
level. Therefore consider the extreme example that r random trees are computed and
that each ti is lower than t. This results in the empirical p-value of 1/r. Thus, r > 1000
random trees are required to achieve a p-value of less than 0.001 and a rejection of H0
at the 0.1% level.
There is no need to use random trees instead of the clustered tree when computing
the p-value. If random trees and randomly permuted labels were used, two variables
would be randomized at the same time. This would lead to an artificially inflated
search space. With the computation of the p-value, we measure the significance of the
correlation between the clustering and the categorical clinical classes. The intention is
not to determine if there is both a significant correlation between the clustering and
the categorical clinical classes and a significant clustering.
The p-value is not altered by the normalization. It is equal for the TI and the NTI.
This is due to the fact that the tree indices are only shifted and scaled in Equation 4.
Thereby, the fraction of ti >t remains unchanged.
Example Let us assume that hierarchical agglomerative clustering of some primary
data leads to a TI of t = 0.688 (Figure 5). Let us further assume that the Monte Carlo
simulation reveals that 18.46% of TIs obtained from ordered cluster trees and ran-
domly permuted labels are higher than t. The resulting p-value of 0.1846 indicates that
H0 (no correlation) cannot be rejected at the 5% level of significance.
Results
The NTI and p-value is applied on two microarray breast cancer data sets. The first
data set is the breast cancer data set of van de Vijver [19] (downloadable at [20]),
TI = 0.649
fre
qu
en
cy
p = 0.1846
TI distribution of random trees
1.51.00 0.5
TI
Figure 5 Computation of an empirical p-value for the TI and NTI. An empirical p-value for the TI (as
well as for the NTI) is obtained using a Monte Carlo simulation: A TI is computed r ≥ 10000 for the same
clustered tree but randomly permuted labels. The p-value is defined by the fraction of TIs that is equal or
higher than the TI obtained from the original label and cluster tree (here: p =18.46%). The resulting p-value
of 0.1846 ≥ 0.05 indicates that there is no significant correlation between the clustered data and the label.
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which is an extension to the study of van’t Veer [7]. For each of the 295 subjects,
24496 genes are analyzed and six nominal clinical parameters are available (Table 1).
The clustering of subjects is performed on logarithms of a set of 231 marker genes
(identified in [7]). The second data set is a preliminary data set taken from the Biele-
feld breast cancer project (BBCP) [21,22]. In the BBCP, a set of 201 marker genes is
analyzed for 87 samples taken from 49 patients. One main feature of the BBCP, in
contrast to other microarray breast cancer studies, is the high number of clinical para-
meters that has been collected for each of the patients. As summarized in Table 2 (left
column), 29 clinical parameters are selected for correlation analysis. Some of these
parameters are interval parameters. To apply the NTI, they have to be converted to
nominal parameters by parameter-specific transformations (e.g., the values of the body
mass index (BMI) are divided into the three categories normal (18.5 to 25), overweight
(25 to 30), and obese (> 30). Moreover, if reasonable, the categories of some nominal
variable are merged (e.g., the categories of the parameter progesterone receptor IHC are
transformed to the categories negative (for values 0 to 1), intermediate (for values 2
to 8) and high positive (for values 9 to 12)). All specific transformations are listed in
Table 2 (right column).
In this paper, the entire molecular expression signature is used to demonstrate the mer-
its of the NTI and its p-value. Available knowledge about the analyzed genes, i.e. informa-
tion about marker genes, is used anyway since this helps to create well-structured cluster
trees. Both data sets (van de Vijver and BBCP) are preprocessed and clustered as follows:
The logarithms of ratios between the respective gene expression to reference sample are
scaled to [-1, 1]. Let xst be the scaled logarithm of sample s and gene t. The expression
profiles xs are clustered by hierarchical agglomerative clustering using average linkage and
a distance metric (dissimilarity measure) based on the correlation between a pair of sub-
jects. This correlation distance metric dij Î [0, 1] of two expression profiles xi and xj of
length g is defined as
d
gij
ik
k
g
jk
= −
=
∑1
2 2
1
x x
(7)
By applying the NTI on cluster trees obtained from real-world data sets, we simulate
the scenario where a biomedical researcher is looking for clinical parameters that are
correlated with the microarray data. The NTI and p-value are computed for each clini-
cal parameter listed in Tables 1 and 2. This enables the detection of even unexpected
relations between the variables. By this approach, huge data collections can be
Table 1 Clinical parameters of the van de Vijver data set
clinical parameter num categories
metastasis 2 (1) no (2) yes
positive lymph nodes 2 (1) no (2) yes
event death 2 (1) no (2) yes
estrogen receptor 2 (1) negative (2) positive
National Institute Health criteria 2 (1) 0 (2) 1
St. Gallen consensus criteria 2 (1) 0 (2) 1
conservative flag 3 (1) 0 (2) 1 (3) 2
The clinical parameters and their categorizations in the van de Vijver breast cancer data set.
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screened without the requirement to manually pre-select the clinical parameters.
Nevertheless, the insight gained depends on the parameter, e.g. the parameter intended
operation rather reveals an unexpected relationship than any insight into a biomedical
process.
A summary of all results is shown in Figure 6. For both data sets, the highest NTI
is obtained for the estrogen receptor. The number of asterisks indicates the level of
significance of the correlation. One asterisk means that the rejection of H0 (no
Table 2 Clinical parameters of the BBCP data set
clinical parameter num categories
age 6 (1) <40 (2) 40 to 49 (3) 50 to 59 (4) 60 to 69 (5) 70 to 79 (6) > 79
sample type 3 (1) biopsie before chemotherapy
(2) biopsie after chemotherapy
(3) operation (after chemotherapy)
BMI 3 (1) normal (18.5 to 25) (2) overweight (25 to 30) (3) obese (> 30)
native country 6 (1) Germany (2) Poland (3) Russia (4) Taiwan (5) Sri Lanka (6) Turkey
ethnic group 2 (1) Europe (2) Asia
nursing 2 (1) no (2) yes
nursing period 4 (1) none (2) short (1 to 5 months) (3) intermediate (6 to 14 months) (4) long
(> 14 months)
menopause 2 (1) no (2) yes
smoking 5 (1) always non-smoker (2) sometimes (3) regular (4) often (5) again
non-smoker
alcohol 5 (1) never (2) no longer (3) less than once a month (4) 1 to 3 times a week (5)
daily
sport 3 (1) nothing (0 h/week) (2) little (1 to 4 h/week) (3) plenty (> 5 h/week)
sleep 3 (1) little (< 7 h/day) (2) normal (7-9 h/day) (3) plenty (> 9 h/day)
familial breast cancer 2 (1) No (2) yes
histology 4 (1) ductal (2) lobar (3) not definable (4) mucous ductal
T (tumor dimension) 5 (1) T0 (2) T1 (3) T2 (4) T3 (5) T4
N (lymph nodes) 3 (1) N0 (2) N1 (3) N2
Grading 2 (1) G2 (2) G3
Progesterone receptor
IHC
3 (1) negative (0 to 1) (2) intermediate (2 to 8) (3) high positive (9 to 12)
Estrogen receptor IHC 3 (1) negative (0 to 1) (2) intermediate (2 to 8) (3) high positive (9 to 12)
Her2-new 3 (1) negative (2) intermediate (3) positive
intended operation 5 (1) ablatio and axilla (2) ablatio and sentinel (3) BET and sentinel (4) ablation
(5) BET
inspection 4 (1) no conspicuity (2) in ammatory mamma-carcinoma (3) plateau
phenomenon (4) other
lateral acoustical
shadow
2 (1) no (2) yes
dorsal acoustic
attenuation
2 (1) no (2) yes
axilla 2 (1) unsuspicious (2) suspicious
tumor size
(mammogramm)
3 (1) small (0 to 9 mm)
(2) intermediate (10 to 25 mm)
(3) large (> 26 mm)
micro lime 2 (1) no (2) yes
chemoregime 5 (1) TAC (2) ACDoc (3) Geparquattro (4) FEC (5) Geparquinto
herceptin treatment 2 (1) no (2) yes
The clinical parameters and their categorizations in the BBCP data set: Interval parameters are converted to nominal
parameters by the indicated transformations in parentheses.
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correlation) is statistically significant at the 5% level, two asterisks at the 1% level,
and three asterisks at the 0.1% level. No asterisk means that H0 cannot be rejected.
On the left of Figure 6, the results for the van de Vijver breast cancer data set are shown.
The highest NTI is obtained for the clinical parameter estrogen receptor (ESR1). The corre-
lation between the clinical parameters metastasis, event death, and estrogen receptor (ESR1)
and the microarray data is statistically significant at the 0.1% level. The StGallen consensus
criteria is statistically significant at the 1% level. On the right of Figure 6, the results for the
BBCP data set are shown. The highest NTI is obtained for estrogen receptor IHC. The cor-
relations between age, BMI, native country, grading, progesterone receptor IHC, and estro-
gen receptor IHC and the microarray data are statistically significant at the 0.1% level. The
correlations of the parameters menopause, smoking, T (tumor dimension), and intended
operation are statistically significant at the 1% level. The correlations of the parameters eth-
nic group, nursing period, alcohol, sleep, N (lymph nodes), Her2-new, inspection, tumor size
(mammogramm) and chemoregime are statistically significant at the 5% level.
The cluster tree of the van de Vijver data set is displayed in Figure 7. It is colored and
evaluated with respect to the clinical parameters positive lymph nodes and estrogen
receptor (ESR1). No correlation is detected between the microarray data and positive
lymph nodes. In contrast to that, the microarray data is highly correlated with estrogen
receptor (ESR1), since the rejection of H0 is statistically significant at the 0.1% level. The
cluster tree of the BBCP data set is displayed in Figure 8. It is colored and evaluated
with respect to the clinical parameters estrogen receptor IHC, progesterone receptor IHC,
grading, and nursing. The p-values < 0.001 indicate that the microarray data is highly
correlated with the first three parameters, whereas there is no correlation with nursing.
Discussion
A novel index, the Normalized Tree Index (NTI), is developed to compute a normal-
ized correlation coefficient between hierarchically clustered primary data (microarray
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Figure 6 Summary of NTIs for the van de Vijver and the BBCP data set. A NTI and p-value is
computed for each clinical parameter. For both data sets, the highest NTI is obtained for the estrogen
receptor. The number of asterisks indicates the level of significance of the correlation. One asterisk means
that the rejection of H0 (no correlation) is statistically significant at the 5% level, two asterisks at the 1%
level, and three asterisks at the 0.1% level. No asterisk means that H0 cannot be rejected.
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data) and nominal labels of secondary data (clinical parameters). The NTI is an exten-
sion to the TI as described in [13], but it is bounded by [0, 1]. A high NTI indicates a
high correlation between the label and the clustered data and vice versa. Furthermore,
an empirical p-value is derived which measures the level of significance of the detected
correlations between labels and primary data.
NTI = 0.0158
p = 0.3022
(TI = 0.6259)
yes
no
positive lymph nodes
positiv
negativ
estrogen receptor (ESR1)
p = 0.0001
NTI = 0.3529
(TI = 3.535)
Figure 7 Cluster tree of the van de Vijver data set. The cluster tree obtained from the van Vijver data
set is colored and evaluated with respect to the clinical parameters positive lymph nodes and estrogen
receptor (ESR1). The p-value of 0.3022 indicates that the microarray data is not correlated with positive
lymph nodes. In contrast to that, the microarray data is highly correlated with estrogen receptor (ESR1).
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Some of the detected correlations reflect common knowledge: The clinical relevance
of the estrogen receptor and the progesterone receptor is unquestioned [23-25]. The
gene expression of these receptors are main criteria to differentiate between genetic
profiles [26-28]. Also, a correlation to metastasis and event death is shown in [7], and
a correlation to grading is reported in [22]. For other detected correlations there is no
clear evidence provided in the literature: The parameters age, BMI, native country,
menopause, smoking, T (tumor dimension) are highly correlated with the genomic data.
These high correlations indicate that there might be common underlying mechanisms
or pathways. The linkages between the phenotypes (the clinical parameters) and the
genotypes (the microarray data) help to formulate new hypothesis and aid to obtain
new insights into the complex mechanisms of diseases. Some of the detected correla-
tions are harder to interpret: The correlations between intended operation, and che-
moregime and the microarray data are probably not based on direct causal
relationships. Interestingly, no significant correlation is reported between the para-
meters familial breast cancer, histology, lateral acoustical shadow, dorsal acoustic
attenuation and the microarray data - an indicator that the genomic information offers
a new approach to access and thus improve the diagnoses of breast cancer.
Even though applied to microarray data in a medical setting, the NTI can be applied
to any complex data, in whose context a cluster analysis of the primary data is reason-
able. Whenever there is the slightest assumption that the internal structure of the pri-
mary data might be correlated with a given label of the secondary data, the NTI
provides an objective measure for this structural relationship.
G2
G3
NTI = 0.1093
(TI = 0.9591)
p = 0.0007
grading
no
yes
NTI = 0.0453
p = 0.5543
(TI = 0.5241)
nursing
high positive (9 to 12)
intermediate (2 to 8)
negative (0 to 1)
NTI = 0.2325
p = 0.0001
(TI = 2.0222)
progesterone receptor IHC
intermediate (2 to 8)
negative (0 to 1)
high positive (9 to 12)
NTI = 0.3438
p = 0.0001
(TI = 2.7173)
estrogen receptor IHC
Figure 8 Cluster tree of the BBCP data set. The cluster tree obtained from the BBCP data set is colored
and evaluated with respect to the clinical parameters estrogen receptor IHC, progesterone receptor IHC,
grading, and nursing. The p-values < 0.001 indicate that the microarray data is highly correlated with the
first three parameters, whereas there is no correlation with nursing.
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The Normalized Tree Index (NTI) is developed to compute a correlation coefficient
between primary data and nominal labels of secondary data. Ordinal and interval labels
have to be converted to nominal labels by label-specific transformations (Table 2). The
correlation result depends on the specific transformation set up by the researcher.
Even though different categorizations for the labels could be tested this way, back-
ground knowledge is required for this step. The transformations also imply a loss of
information. However, a reduction of the data of an ordinal or interval parameter to a
few biological relevant categories can also help to avoid over fitting. In Table 2, the
interval-scaled clinical labels progesterone receptor IHC and estrogen receptor IHC have
been transformed to nominal labels with three categories: negative (0 to 1), intermedi-
ate (2 to 8) and high positive (9 to 12). Nevertheless, strategies for a direct application
of the NTI on ordinal and interval labels need to be developed.
Hierarchical agglomerative clustering and the computation of the NTI are advanta-
geous compared to the following method that is sometimes used to obtain a correla-
tion coefficient: A classifier is trained on the microarray data. A selected label is used
to rate the correlation depending on the ability of a classifier to predict the correct
label in a leave-one-out setting. The higher the classification rate, the higher the corre-
lation between the primary data and the label. The major drawback of this approach is
that a visualization is not provided this way. A high classification rate indicates a high
correlation, but there is no way to retrace how the specific classification rate has been
obtained. Homogeneous clusters, outliers, and other significant patterns cannot be
identified this way.
Conclusion
The Normalized Tree Index (NTI) is the first cluster index that uses the structure of
the hierarchical clustering tree to compute a normalized correlation coefficient
between nominal labels and high-dimensional primary data. Its normalization feature
enables the easy identification of labels that are correlated with the primary data, while
at the same time a p-value measures the level of significance of the detected correla-
tions. Even though applied to microarray data in a medical setting, the NTI can be
applied to any complex data. This general applicability makes it a powerful tool in
diverse domains.
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